76 related articles for article (PubMed ID: 26874203)
1. Proteolytic cleavage in the S1-S2 linker of the Kv1.5 channel does not affect channel function.
Hogan-Cann A; Li W; Guo J; Yang T; Zhang S
Biochim Biophys Acta; 2016 Jun; 1858(6):1082-90. PubMed ID: 26874203
[TBL] [Abstract][Full Text] [Related]
2. Mechanical stretch increases Kv1.5 current through an interaction between the S1-S2 linker and N-terminus of the channel.
Milton AO; Wang T; Li W; Guo J; Zhang S
J Biol Chem; 2020 Apr; 295(14):4723-4732. PubMed ID: 32122972
[TBL] [Abstract][Full Text] [Related]
3. The N terminus and transmembrane segment S1 of Kv1.5 can coassemble with the rest of the channel independently of the S1-S2 linkage.
Lamothe SM; Hogan-Cann AE; Li W; Guo J; Yang T; Tschirhart JN; Zhang S
J Biol Chem; 2018 Oct; 293(40):15347-15358. PubMed ID: 30121572
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
[TBL] [Abstract][Full Text] [Related]
5. Allowed N-glycosylation sites on the Kv1.2 potassium channel S1-S2 linker: implications for linker secondary structure and the glycosylation effect on channel function.
Zhu J; Watanabe I; Poholek A; Koss M; Gomez B; Yan C; Recio-Pinto E; Thornhill WB
Biochem J; 2003 Nov; 375(Pt 3):769-75. PubMed ID: 12911333
[TBL] [Abstract][Full Text] [Related]
6. Dynamics and modulation studies of human voltage gated Kv1.5 channel.
Bhuyan R; Seal A
J Biomol Struct Dyn; 2017 Feb; 35(2):380-398. PubMed ID: 26786269
[TBL] [Abstract][Full Text] [Related]
7. Voltage- and time-dependent block by perhexiline of K+ currents in human atrium and in cells expressing a Kv1.5-type cloned channel.
Rampe D; Wang Z; Fermini B; Wible B; Dage RC; Nattel S
J Pharmacol Exp Ther; 1995 Jul; 274(1):444-9. PubMed ID: 7616429
[TBL] [Abstract][Full Text] [Related]
8. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
Li P; Kurata Y; Maharani N; Mahati E; Higaki K; Hasegawa A; Shirayoshi Y; Yoshida A; Kondo T; Kurozawa Y; Yamamoto K; Ninomiya H; Hisatome I
J Mol Cell Cardiol; 2015 Sep; 86():138-46. PubMed ID: 26232501
[TBL] [Abstract][Full Text] [Related]
9. The Kv1.2 potassium channel: the position of an N-glycan on the extracellular linkers affects its protein expression and function.
Zhu J; Recio-Pinto E; Hartwig T; Sellers W; Yan J; Thornhill WB
Brain Res; 2009 Jan; 1251():16-29. PubMed ID: 19056359
[TBL] [Abstract][Full Text] [Related]
10. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
11. SNX17 (Sorting Nexin 17) Mediates Atrial Fibrillation Onset Through Endocytic Trafficking of the Kv1.5 (Potassium Voltage-Gated Channel Subfamily A Member 5) Channel.
Geng L; Wang S; Zhang F; Xiong K; Huang J; Zhao T; Shi D; Lv F; Li L; Liang D; Cui Y; Liu Y; Xie D; Chen YH
Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e007097. PubMed ID: 30939909
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modification of voltage-dependent potassium channel Kv1.5: COOH-terminal palmitoylation modulates its biological properties.
Jindal HK; Folco EJ; Liu GX; Koren G
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2012-21. PubMed ID: 18344374
[TBL] [Abstract][Full Text] [Related]
13. Kv1.5 channels are regulated by PKC-mediated endocytic degradation.
Du Y; Wang T; Guo J; Li W; Yang T; Szendrey M; Zhang S
J Biol Chem; 2021; 296():100514. PubMed ID: 33676894
[TBL] [Abstract][Full Text] [Related]
14. State-dependent block of rabbit vascular smooth muscle delayed rectifier and Kv1.5 channels by inhibitors of cytochrome P450-dependent enzymes.
Iftinca M; Waldron GJ; Triggle CR; Cole WC
J Pharmacol Exp Ther; 2001 Aug; 298(2):718-28. PubMed ID: 11454936
[TBL] [Abstract][Full Text] [Related]
15. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Fedida D; Eldstrom J; Hesketh JC; Lamorgese M; Castel L; Steele DF; Van Wagoner DR
Circ Res; 2003 Oct; 93(8):744-51. PubMed ID: 14500335
[TBL] [Abstract][Full Text] [Related]
16. Kv1.5 surface expression is modulated by retrograde trafficking of newly endocytosed channels by the dynein motor.
Choi WS; Khurana A; Mathur R; Viswanathan V; Steele DF; Fedida D
Circ Res; 2005 Aug; 97(4):363-71. PubMed ID: 16051887
[TBL] [Abstract][Full Text] [Related]
17. KChIP2 modulates the cell surface expression of Kv 1.5-encoded K(+) channels.
Li H; Guo W; Mellor RL; Nerbonne JM
J Mol Cell Cardiol; 2005 Jul; 39(1):121-32. PubMed ID: 15878168
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
19. Voltage gated K+ channel expression in arteries of Wistar-Kyoto and spontaneously hypertensive rats.
Cox RH; Fromme SJ; Folander KL; Swanson RJ
Am J Hypertens; 2008 Feb; 21(2):213-8. PubMed ID: 18174882
[TBL] [Abstract][Full Text] [Related]
20. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
